Sept 28 (Reuters) - Pfizer Inc and BioNTech SE
on Tuesday asked U.S. health regulators to authorize
their COVID-19 vaccine in kids aged 5 to 11.
The application to the U.S. Food and Drug Administration
comes as COVID-19 infections have soared in children, hitting
their highest point in early September, according to data from
the American Academy of Pediatrics.
(Reporting by Manas Mishra in Bengaluru; Editing by Saumyadeb